Asthma Clinical Trials in Los Angeles

Showing 81-100 of 256 trials

Predictors of Severe COVID-19 Outcomes

NCT04388813

This is a longitudinal, multi-center, observational study collecting diverse biological measurements and clinical and epidemiological data for the purpose of enabling a greater understanding of the onset of severe outcomes, primarily acute respiratory distress syndrome (ARDS) and/or mortality, in patients presenting to the hospital with suspicion or diagnosis of COVID-19. We seek to understand whether there are early signatures that predict progression to ARDS, mortality, and/or other comorbid conditions. The duration of the study participation is approximately 3 months.

Acute Respiratory Distress SyndromeCOVID-19

Verily Life Sciences LLC494 participantsStarted May 2020

Tucson, Arizona, United States • Los Angeles, California, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 2< 1 mile

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

NCT04570657

Study D9181C00001 is a Phase II, randomised, double-blind, placebo-controlled, parallel group, proof of concept study to evaluate the efficacy, safety, pharmacokinetics (PK) and immunogenicity of MEDI3506 in adult participants with uncontrolled moderate to severe asthma on standard of care (SOC). Up to approximately 80 sites globally will participate in this study. Approximately 228 participants will be randomized to 3 treatment groups in a 1:1:1 ratio to receive MEDI3506 dose 1, MEDI3506 dose 2, or placebo.

Asthma

AstraZeneca250 participantsStarted Sep 2020

Bakersfield, California, United States • Los Angeles, California, United States • Newport Beach, California, United States +62 more locations

Predictors of Severe COVID-19 Outcomes

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Asthma Trials in Other Cities

A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration

A Study of ARRY-502 in Patients With Persistent Asthma

Evaluating Pressures During Non-invasive Ventilation Utilizing NIV Plus Software

A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

COVID-19 and Anti-CD14 Treatment Trial

International Lung Screen Trial (ILST)

Other Conditions in Los Angeles